Barclays PLC vs Hims and Hers Health Inc — how do they compare? Barclays PLC trades at $27.92 (market cap $92.56B), while Hims and Hers Health Inc trades at $35.54 (market cap $8.14B). The key difference: Barclays PLC is far larger — about 11.4× Hims and Hers Health Inc's market cap, and Barclays PLC pays a 1.67% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals.
| BCS | HIMS | |
|---|---|---|
Market Cap | $92.56B | $8.14B |
Sector | Financials | Health |
52-Week High | $28.41 | $66.18 |
52-Week Low | $18.48 | $14.52 |
Dividend Yield | 1.67% | — |
Enterprise Value | — | $8.52B |
Signals from Pluang's Aura AI — not financial advice
Barclays PLC (BCS) trades at $27.29, down 0.69% on the day, near its 52-week high of $28.43. The stock shows strong fundamental momentum with revenue rising to $29.14B in 2025 and net income reaching $7.17B, supported by three consecutive quarterly EPS beats. Technical indicators signal a bullish trend, while analyst sentiment remains positive with 68% buy ratings. Recent news highlights ongoing legal investigations but also underscores the bank's role in market analysis and product innovation.
The outlook for BCS is cautiously optimistic, driven by solid earnings growth and attractive valuation metrics like a P/E of 11.91 and P/B of 0.91. Key risks include potential legal liabilities from securities investigations and macroeconomic sensitivity. Investors should weigh the strong analyst support against these headwinds for balanced decision-making.
No Aura AI signal available yet.
Trailing returns across standard periods
Barclays is a universal bank headquartered in the United Kingdom. It operates via two principal segments
Read more on BCS →Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →